Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village

被引:14
|
作者
Shehab, S
Keller, N
Barkay, A
Leitner, L
Leventhal, A
Block, C
机构
[1] Israel Minist Hlth, Akko Publ Hlth Off, IL-24120 Akko, Israel
[2] Chaim Sheba Med Ctr, Natl Ctr Meningococci, IL-52621 Tel Hashomer, Israel
[3] Israel Minist Hlth, Nazareth Publ Hlth Off, IL-17000 Nazareth, Israel
[4] Israel Minist Hlth, Publ Hlth Serv, IL-91010 Jerusalem, Israel
[5] Hadassah Univ Hosp, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel
关键词
D O I
10.1007/s100960050179
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In January 1994 mass antibiotic prophylaxis was undertaken in the contiguous villages of Deir el-Asad and B'ine in northern Israel (combined population of 11600) in response to a prolonged outbreak of serogroup B meningococcal infection with an overall annual rate of 37.4 cases of infection per 100000 residents. The average case fatality rate in the villages was 23% compared with 11% in Israel during the same period. Neisseria meningitidis group B was identified in 9 of 13 (69%) cases. Seven of these were subtype P1.7,16. The persistence of the outbreak with its accompanying public reaction prompted the establishment of an intervention programme that included antibiotic prophylaxis for the whole community with monitoring for pharyngeal carriage of meningococci in a stratified sample of the population. The objectives were to achieve a reduction of carriage of the outbreak strain and to reduce morbidity and mortality. A total of 1036 pharyngeal swabs were taken 1 day before and 6 weeks after treatment. Antibiotic prophylaxis was administered in one dose: children under 5-years-old received ceftriaxone i.m.; all others received oral ciprofloxacin. Overall, 96% of the population received treatment. The carriage rate was 8.3% prior to treatment (three serogroup B:14:P1.7,16), and 1.3% afterwards (one serogroup B:14:P1.7,16). The intervention failed to eradicate carriage of the putative outbreak strain, or to reduce the incidence and fatality rates in the villages. The outbreak finally terminated in late 1996. Public health professionals should bear this experience in mind when faced with prolonged, localized, nonexplosive outbreaks of meningococcal disease associated with low carriage rates of the outbreak strain.
引用
收藏
页码:749 / 753
页数:5
相关论文
共 32 条
  • [1] Failure of Mass Antibiotic Prophylaxis to Control a Prolonged Outbreak of Meningococcal Disease in an Israeli Village
    S. Shehab
    N. Keller
    A. Barkay
    L. Leitner
    A. Leventhal
    C. Block
    European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 : 749 - 753
  • [2] Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis
    Katz, L. H.
    Zelazny, A.
    Scharf, S.
    Hourvitz, A.
    Asor, N.
    Arbeli, Y.
    Yust-Katz, S.
    Smollan-Fredman, G.
    Gdalevich, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (09) : 943 - 946
  • [3] Antibiotic prescribing during an outbreak of meningococcal disease
    Stuart, JM
    Robinson, PM
    Cartwright, K
    Noah, ND
    EPIDEMIOLOGY AND INFECTION, 1996, 117 (01): : 103 - 105
  • [4] Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease
    Crew, Page E.
    McNamara, Lucy
    Waldron, Peter E.
    McCulley, Lynda
    Jones, S. Christopher
    Bersoff-Matcha, Susan J.
    JOURNAL OF INFECTION, 2020, 80 (03) : 359 - 361
  • [5] Meningococcal meningitis group A: A successful control of an outbreak by mass vaccination
    ElBushra, HE
    Mawlawi, MY
    Fontaine, RE
    Afif, H
    EAST AFRICAN MEDICAL JOURNAL, 1995, 72 (11) : 715 - 718
  • [6] Mass vaccination campaign following community outbreak of meningococcal disease
    Krause, G
    Blackmore, C
    Wiersma, S
    Lesneski, C
    Gauch, L
    Hopkins, RS
    EMERGING INFECTIOUS DISEASES, 2002, 8 (12) : 1398 - 1403
  • [7] Mass chemoprophylaxis for control of outbreaks of meningococcal disease
    McNamara, Lucy A.
    MacNeil, Jessica R.
    Cohn, Amanda C.
    Stephens, David S.
    LANCET INFECTIOUS DISEASES, 2018, 18 (09): : E272 - E281
  • [8] FAILURE TO PREVENT CO-PRIMARY CASES OF MENINGOCOCCAL DISEASE WITH RIFAMPICIN PROPHYLAXIS
    KACZMARSKI, EB
    JONES, DM
    JOURNAL OF INFECTION, 1992, 24 (01) : 110 - 111
  • [9] Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis
    Torres, Renato Pedro de Almeida
    Torres, Romulo Francisco de Almeida
    Crombrugghe, Gabrielle de
    Moraes da Silva, Scarllet Palacin
    Cordeiro, Sarah Leticia Veroneze
    Bosi, Karine Alessandra
    Smeesters, Pierre R.
    Torres, Rosangela Stadnick Lauth de Almeida
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [10] The importance of surveillance: Group W meningococcal disease outbreak response and control in England
    Campbell, Helen
    Ladhani, Shamez
    INTERNATIONAL HEALTH, 2016, 8 (06): : 369 - 371